• 1
    Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2004;4:6977.
  • 2
    Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev 2004;202:832.
  • 3
    Uzé G, Monneron D. IL-28 and IL-29: newcomers to the interferon family. Biochimie 2007;89:729734.
  • 4
    Jordan WJ, Eskdale J, Srinivas S, Pekarek V, Kelner D, Rodia M et al. Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response. Genes Immun 2007;8:254261.
  • 5
    Mennechet FJ, Uzé G. Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells. Blood 2006;107:44174423.
  • 6
    Kalesnikoff J, Galli SJ. New developments in mast cell biology. Nat Immunol 2008;9:12151223.
  • 7
    Okayama Y, Ra C, Saito H. Role of mast cells in airway remodeling. Curr Opin Immunol 2007;19:687693.
  • 8
    Harvima IT, Nilsson G, Suttle MM, Naukkarinen A. Is there a role for mast cells in psoriasis? Arch Dermatol Res 2008;300:461478.
  • 9
    Bischoff SC, Krämer S. Human mast cells, bacteria, and intestinal immunity. Immunol Rev 2007;217:329337.
  • 10
    Forbes EE, Groschwitz K, Abonia JP, Brandt EB, Cohen E, Blanchard C et al. IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J Exp Med 2008;205:897913.
  • 11
    Zheng PY, Feng BS, Oluwole C, Struiksma S, Chen X, Li P et al. Psychological stress induces eosinophils to produce corticotrophin releasing hormone in the intestine. Gut 2009;58:14731479.
  • 12
    He S, Gaca MD, Walls AF. A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase. J Pharmacol Exp Ther 1998;286:289297.
  • 13
    He S, Gaca MD, McEuen AR, Walls AF. Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells. J Pharmacol Exp Ther 1999;291:517523.
  • 14
    Zhang HY, Yang XY, Yang HW, Lin Q, Zhang ZF, Zheng YS et al. Modulation of proteinase activated receptor expression and IL-4 release from mast cells by IL-12. Immunol Cell Biol 2007;85:558566.
  • 15
    He S, Peng Q, Walls AF. Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: selective enhancement of eosinophil recruitment by histamine. J Immunol 1997;159:62166225.
  • 16
    Williams CM, Coleman JW. Induced expression of mRNA for IL-5, IL-6, TNF-alpha, MIP-2 and IFN-gamma in immunologically activated rat peritoneal mast cells: inhibition by dexamethasone and cyclosporin A. Immunology 1995;86:244249.
  • 17
    Chiba N, Masuda A, Yoshikai Y, Matsuguchi T. Ceramide inhibits LPS-induced production of IL-5, IL-10, and IL-13 from mast cells. J Cell Physiol 2007;213:126136.
  • 18
    Kim JS, Ouyang F, Pongracic JA, Fang Y, Wang B, Liu X et al. Dissociation between the prevalence of atopy and allergic disease in rural China among children and adults. J Allergy Clin Immunol 2008;122:929935.
  • 19
    Zhang ZF, Zhang HY, Yang HW, Zhang LX, Chen C, Zheng XX et al. Induction of Th2 cytokine release and upregulated expression of protease activated receptors on mast cells by recombinant American cockroach allergen Per a 7. Clin Exp Allergy 2008;38:11601167.
  • 20
    Lukacs NW, Kunkel SL, Strieter RM, Evanoff HL, Kunkel RG, Key ML et al. The role of stem cell factor (c-kit ligand) and inflammatory cytokines in pulmonary mast cell activation. Blood 1996;87:22622268.
  • 21
    Wong CK, Tsang CM, Ip WK, Lam CW. Molecular mechanisms for the release of chemokines from human leukemic mast cell line (HMC)-1 cells activated by SCF and TNF-alpha: roles of ERK, p38 MAPK, and NF-kappaB. Allergy 2006;61:289297.
  • 22
    Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte JM et al. IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am J Physiol Gastrointest Liver Physiol 2005;289:G960G968.
  • 23
    Lasfar A, Lewis-Antes A, Smirnov SV, Anantha S, Abushahba W, Tian B et al. Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma. Cancer Res 2006;66:44684477.
  • 24
    Feng BS, Zheng PY, Chen X, Liao XQ, Yang PC. Investigation of the role of cholera toxin in assisting the initiation of the antigen-specific Th2 response. Immunol Invest 2008;37:782797.
  • 25
    Sun J, Pearce EJ. Suppression of early IL-4 production underlies the failure of CD4 T cells activated by TLR-stimulated dendritic cells to differentiate into Th2 cells. J Immunol 2007;178:16351644.
  • 26
    Donnelly RP, Sheikh F, Kotenko SV, Dickensheets H. The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J Leukoc Biol 2004;76:314321.
  • 27
    Avery DT, Ma CS, Bryant VL, Santner-Nanan B, Nanan R, Wong M et al. STAT3 is required for IL-21-induced secretion of IgE from human naive B cells. Blood 2008;112:17841793.
  • 28
    Lin TJ, Issekutz TB, Marshall JS. Human mast cells transmigrate through human umbilical vein endothelial monolayers and selectively produce IL-8 in response to stromal cell-derived factor-1 alpha. J Immunol 2000;165:211220.
  • 29
    Huang B, Lei Z, Zhang GM, Li D, HSong C, Li Y et al. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood 2008;112:12691279.
  • 30
    Dvorak AM, Tepper RI, Weller PF, Morgan ES, HEstrella P, Monahan-Earley RA et al. Piecemeal degranulation of mast cells in the inflammatory eyelid lesions of interleukin-4 transgenic mice. Evidence of mast cell histamine release in vivo by diamine oxidase-gold enzyme-affinity ultrastructural cytochemistry. Blood 1994;83:36003612.
  • 31
    Wu Y, Ip JE, Huang J, Zhang L, HMatsushita K, Liew CC et al. Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium. Circ Res 2006;99:315322.
  • 32
    Toru H, Kinashi T, Ra C, Nonoyama S, Yata J, Nakahata T. Interleukin-4 induces homotypic aggregation of human mast cells by promoting LFA-1/ICAM-1 adhesion molecules. Blood 1997;89:32963302.
  • 33
    Shimada Y, Hasegawa M, Kaburagi Y, Hamaguchi Y, HKomura K, Saito E et al. L-selectin or ICAM-1 deficiency reduces an immediate-type hypersensitivity response by preventing mast cell recruitment in repeated elicitation of contact hypersensitivity. J Immunol 2003;170:43254334.